Role of heregulin in human cancer
- PMID: 17530167
- PMCID: PMC11138466
- DOI: 10.1007/s00018-007-7120-0
Role of heregulin in human cancer
Abstract
Heregulin (HRG) is a soluble secreted growth factor, which, upon binding and activation of ErbB3 and ErbB4 transmembrane receptor tyrosine kinases, is involved in cell proliferation, invasion, survival and differentiation of normal and malignant tissues. The HRG gene family consists of four members: HRG-1, HRG-2, HRG-3 and HRG-4, of which a multitude of different isoforms are synthesized by alternative exon splicing, showing various tissue distribution and biological activities. Disruption of the physiological balance between HRG ligands and their ErbB receptors is implicated in the formation of a variety of human cancers. The general mechanisms involved in HRG-induced tumorigenesis is discussed.
Similar articles
-
Essential role for Rac in heregulin beta1 mitogenic signaling: a mechanism that involves epidermal growth factor receptor and is independent of ErbB4.Mol Cell Biol. 2006 Feb;26(3):831-42. doi: 10.1128/MCB.26.3.831-842.2006. Mol Cell Biol. 2006. PMID: 16428439 Free PMC article.
-
A naturally occurring secreted human ErbB3 receptor isoform inhibits heregulin-stimulated activation of ErbB2, ErbB3, and ErbB4.Cancer Res. 2001 Jun 1;61(11):4467-73. Cancer Res. 2001. PMID: 11389077
-
Heregulin (HRG)-induced mitogenic signaling and cytotoxic activity of a HRG/PE40 ligand toxin in human breast cancer cells.Cell Growth Differ. 1995 Dec;6(12):1567-77. Cell Growth Differ. 1995. PMID: 9019162
-
The neuregulin-I/ErbB signaling system in development and disease.Adv Anat Embryol Cell Biol. 2007;190:1-65. Adv Anat Embryol Cell Biol. 2007. PMID: 17432114 Review.
-
Heregulin in breast cancer: old story, new paradigm.Curr Pharm Des. 2014;20(30):4874-8. doi: 10.2174/1381612819666131125151519. Curr Pharm Des. 2014. PMID: 24283953 Review.
Cited by
-
Genetic variants associated with serum thyroid stimulating hormone (TSH) levels in European Americans and African Americans from the eMERGE Network.PLoS One. 2014 Dec 1;9(12):e111301. doi: 10.1371/journal.pone.0111301. eCollection 2014. PLoS One. 2014. PMID: 25436638 Free PMC article.
-
Overcoming brain-derived therapeutic resistance in HER2+ breast cancer brain metastasis.bioRxiv [Preprint]. 2024 Feb 22:2024.02.19.581073. doi: 10.1101/2024.02.19.581073. bioRxiv. 2024. PMID: 38529509 Free PMC article. Preprint.
-
Adenovirus-Derived Nano-Capsid Platforms for Targeted Delivery and Penetration of Macromolecules into Resistant and Metastatic Tumors.Cancers (Basel). 2023 Jun 19;15(12):3240. doi: 10.3390/cancers15123240. Cancers (Basel). 2023. PMID: 37370850 Free PMC article. Review.
-
Scattering of MCF7 cells by heregulin ß-1 depends on the MEK and p38 MAP kinase pathway.PLoS One. 2013;8(1):e53298. doi: 10.1371/journal.pone.0053298. Epub 2013 Jan 7. PLoS One. 2013. PMID: 23308187 Free PMC article.
-
The immunoglobulin-like domain of neuregulins potentiates ErbB3/HER3 activation and cellular proliferation.Mol Oncol. 2018 Jun;12(7):1061-1076. doi: 10.1002/1878-0261.12310. Epub 2018 May 14. Mol Oncol. 2018. PMID: 29683256 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous